Tokyo Tape
Sign in
← PHC Holdings

Quarterly report · Q1

6523.TEDINET S100RO21
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥81.3bn2023-04-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥356.4bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥81.5bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Operating income¥1.7bn2023-04-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥2.0bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Profit before tax−¥3.6bn2023-04-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax¥179m2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Net income (owners)−¥3.2bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥3.2bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥7.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income−¥3.1bn2023-04-01 → 2023-06-30Cons.Profit loss IFRS
Net income−¥7.0bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Total assets¥572.5bnat 2023-06-30Cons.Assets IFRS
Total assets¥561.6bnat 2023-03-31Cons.Assets IFRS
Total assets¥595.7bnat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥428.9bnat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥422.7bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥143.7bnat 2023-06-30Cons.Equity IFRS
Net assets / equity¥138.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥137.7bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥136.1bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥144.0bnat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥138.0bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥136.9bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥54.1bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.9bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥82.1bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥95.2bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥8.2bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥21.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥1.9bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.5bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥17.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥5.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥14.4bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥40.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥11.9bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-25.52023-04-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-25.842022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-57.262022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-25.52023-04-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-25.842022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-57.262022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio25.2%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.6%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio23.0%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30¥568m
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-06-30¥568m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥2.2bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue2023-04-01 → 2023-06-30¥25.4bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue external2023-04-01 → 2023-06-30¥25.4bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.6bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2023-04-01 → 2023-06-30¥24.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2023-04-01 → 2023-06-30¥24.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.2bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue2023-04-01 → 2023-06-30¥30.8bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue external2023-04-01 → 2023-06-30¥30.8bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.2bn
—segment totalrevenue2023-04-01 → 2023-06-30¥80.8bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥80.8bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥3.9bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30¥552m
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-06-30¥552m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥6.7bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue2022-04-01 → 2022-06-30¥26.5bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue external2022-04-01 → 2022-06-30¥26.5bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentsegment profit2022-04-01 → 2022-06-30¥5.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2022-04-01 → 2022-06-30¥23.4bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2022-04-01 → 2022-06-30¥23.4bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue2022-04-01 → 2022-06-30¥31.1bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue external2022-04-01 → 2022-06-30¥31.1bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.0bn
—segment totalrevenue2022-04-01 → 2022-06-30¥80.9bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥80.9bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥8.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 864
ItemContextValueUnit
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember211900
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember125598700
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember1255987
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember18250
Number of shares issued shares voting rightsCurrentQuarterInstant125828850
Number of voting rights issued shares voting rightsCurrentQuarterInstant1255987
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member211900
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member211900
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0017
Number of shares held in own name treasury shares etcCurrentQuarterInstant211900
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant211900
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0017
Cash and cash equivalents IFRSPrior1YearInstant60933000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant54066000000JPY
Trade receivables ca IFRSPrior1YearInstant69280000000JPY
Trade receivables ca IFRSCurrentQuarterInstant63944000000JPY
Inventories ca IFRSPrior1YearInstant51732000000JPY
Inventories ca IFRSCurrentQuarterInstant58284000000JPY
Other financial assets ca IFRSPrior1YearInstant2321000000JPY
Other financial assets ca IFRSCurrentQuarterInstant3065000000JPY
Other current assets ca IFRSPrior1YearInstant13070000000JPY
Other current assets ca IFRSCurrentQuarterInstant13433000000JPY
Current assets other than assets held for sale ca IFRSPrior1YearInstant197339000000JPY
Current assets other than assets held for sale ca IFRSCurrentQuarterInstant192795000000JPY
Assets held for sale IFRSPrior1YearInstant244000000JPY
Assets held for sale IFRSCurrentQuarterInstant2211000000JPY
Current assets IFRSPrior1YearInstant197583000000JPY
Current assets IFRSCurrentQuarterInstant195006000000JPY
Property plant and equipment IFRSPrior1YearInstant47593000000JPY
Property plant and equipment IFRSCurrentQuarterInstant48316000000JPY
Goodwill IFRSPrior1YearInstant199707000000JPY
Goodwill IFRSCurrentQuarterInstant211228000000JPY
Intangible assets IFRSPrior1YearInstant91123000000JPY
Intangible assets IFRSCurrentQuarterInstant93973000000JPY
Investments accounted for using equity method IFRSPrior1YearInstant3697000000JPY
Investments accounted for using equity method IFRSCurrentQuarterInstant2255000000JPY
Other financial assets nca IFRSPrior1YearInstant16107000000JPY
Other financial assets nca IFRSCurrentQuarterInstant16208000000JPY
Deferred tax assets IFRSPrior1YearInstant4425000000JPY
Deferred tax assets IFRSCurrentQuarterInstant4148000000JPY
Other non current assets nca IFRSPrior1YearInstant1328000000JPY
Other non current assets nca IFRSCurrentQuarterInstant1408000000JPY
Non current assets IFRSPrior1YearInstant363984000000JPY
Non current assets IFRSCurrentQuarterInstant377540000000JPY
Assets IFRSPrior1YearInstant561567000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass